Skip to content

The effect of extracranial direct current stimulation, schema therapy on vaginismus

Compare effectiveness of transcranial direct current stimulation (Tdcs), schema therapy and combination therapy on anxiety, sexual pain and executive functions in women with vaginismus

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220123053808N1
Enrollment
60
Registered
2022-09-11
Start date
2022-07-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginismus. Vaginismus

Interventions

Intervention 1: The first intervention group: providing transcranial electrical stimulation of the brain using direct current (tDCS) in the form of ten 20-minute sessions with an intensity of two mill

Sponsors

University of Lorestan
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: All women diagnosed with vaginismus disorder who have at least a diploma. All women diagnosed with vaginismus disorder who do not have psychotic symptoms. All women diagnosed with vaginismus disorder who do not have substance abuse and psychological disorders (as diagnosed by a psychiatrist or psychologist). All women diagnosed with vaginismus disorder who do not have gynecological diseases (such as infection). All women diagnosed with vaginismus disorder who have been married for at least 1 to 3 years.

Exclusion criteria

Exclusion criteria: All women who have any disorder except vaginismus disorder. All women who have symptoms similar to vaginismus but do not have a Gynecologist diagnosis. All women who are not married or have been married for less than a year. All women who are under 18 years old and over 50 years old. All women who have symptoms of psychosis and take nerve medication. All women whose educational qualification is below diploma.

Design outcomes

Primary

MeasureTime frame
Primary outcome: sexual pain score. Timepoint: 1 to 5 days before the intervention and 1 to 5 days after the intervention. Method of measurement: McGill pain questionnaire.;Secondary outcome: anxiety score. Timepoint: 1 to 5 days before the intervention and 1 to 5 days after the intervention. Method of measurement: Kettle Anxiety Questionnaire.;Individual's executive performance scores. Timepoint: 1 to 5 days before the intervention and 1 to 5 days after the intervention. Method of measurement: Nback memory test, Wisconsin test, Semantic Stroop test.

Secondary

MeasureTime frame
Sexual pain score. Timepoint: Before intervention and after intervention. Method of measurement: McGill Sexual Pain Questionnaire 22 questions.;Anxiety. Timepoint: Before intervention and after intervention. Method of measurement: Kettle Anxiety Questionnaire 40 questions.;Executive functions. Timepoint: Before intervention and after intervention. Method of measurement: Semantic Strope, NB Memory Test, Wisconsin Test.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmotahareh nosratabadi

the university of lorestan

motinosi1367@gmail.com+98 921 076 1741

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026